RNS Number : 8867Z
London Stock Exchange Notice
17 January 2024
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE
17/01/2024 - 08:00
At the request of the company the following securities have been cancelled from admission to trading on London Stock Exchange with effect from the time and date of this notice.
|
DECHRA PHARMACEUTICALS PLC
|
|
213800J4UVB5OWG8VX82
|
|
ORDINARY SHARES OF 1P EACH FULLY PAID
|
(0963318)(GB0009633180)
|
DECA PHAR/PAR VTG FPD 0.01
|
If you have any queries relating to the above, please contact Market Operations at the London Stock Exchange on 020 7797 4310.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
SENGPUPAGUPCGWQ
